Tauroursodeoxycholic Acid Protects Retinal and Visual Function in a Mouse Model of Type 1 Diabetes.

DM+TUDCA groups with either early and late treatment had negative slopes across time, indicating improved decreased implicit times with treatment ( Figure 5 E, early treatment slope, −0.38 ± 0.63; Figure 5 F, late treatment slope, −0.54 ± 0.44), while DM+Veh groups showed increasing times ( Figure 5 E,F), although these trends did not reach statistical significance. 4.

also in 111,027 other papers